174 related articles for article (PubMed ID: 37421537)
21. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
[TBL] [Abstract][Full Text] [Related]
22. Interstitial lung disease in non-sicca onset primary Sjögren's syndrome: a large-scale case-control study.
Gao H; Zou YD; Zhang XW; He J; Zhang J; Sun Y; Li ZG
Int J Rheum Dis; 2018 Jul; 21(7):1423-1429. PubMed ID: 29968329
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Kamiya Y; Fujisawa T; Kono M; Nakamura H; Yokomura K; Koshimizu N; Toyoshima M; Imokawa S; Sumikawa H; Johkoh T; Yasui H; Hozumi H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
Respir Med; 2019 Nov; 159():105811. PubMed ID: 31710871
[TBL] [Abstract][Full Text] [Related]
24. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers of interstitial lung disease associated with primary Sjögren's syndrome.
Weng L; Chen Y; Liang T; Lin Y; Liu D; Yu C; Hu Y; Lui W; Liu Y; Chen X; Li Q; Ge S; Ascherman DP; Chen J
Eur J Med Res; 2022 Oct; 27(1):199. PubMed ID: 36217184
[TBL] [Abstract][Full Text] [Related]
26. Interstitial lung disease in primary Sjögren syndrome.
Parambil JG; Myers JL; Lindell RM; Matteson EL; Ryu JH
Chest; 2006 Nov; 130(5):1489-95. PubMed ID: 17099028
[TBL] [Abstract][Full Text] [Related]
27. Clinical and laboratory profiles of primary Sjogren's syndrome in a Chinese population: A retrospective analysis of 315 patients.
Li X; Xu B; Ma Y; Li X; Cheng Q; Wang X; Wang G; Qian L; Wei L
Int J Rheum Dis; 2015 May; 18(4):439-46. PubMed ID: 25925697
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren's syndrome-related interstitial lung disease.
Shi L; Fu Q; Chen N; Liu R; Zheng Y
Clin Exp Med; 2020 Aug; 20(3):393-399. PubMed ID: 32253547
[TBL] [Abstract][Full Text] [Related]
29. Interstitial lung disease in Sjögren's syndrome: a clinical review.
Luppi F; Sebastiani M; Silva M; Sverzellati N; Cavazza A; Salvarani C; Manfredi A
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):291-300. PubMed ID: 33095142
[TBL] [Abstract][Full Text] [Related]
30. Anti-parietal cell antibodies as a potential biomarker for interstitial lung disease associated with primary Sjögren's syndrome.
Zhang N; Wang H; Sun W; Hou H; Du J; Xu J; Wei W
Med Clin (Barc); 2024 Jan; 162(1):1-8. PubMed ID: 37596162
[TBL] [Abstract][Full Text] [Related]
31. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary manifestations of Sjögren's syndrome.
Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
[TBL] [Abstract][Full Text] [Related]
33. Serum bilirubin levels in primary Sjögren's syndrome: an association with interstitial lung disease.
Peng YF; Lu FY; Ma LY
BMC Pulm Med; 2023 Sep; 23(1):366. PubMed ID: 37777728
[TBL] [Abstract][Full Text] [Related]
34. Circulating Th2 cell reduction and Th1/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease.
Shi L; Wang J; Guo HX; Han XL; Tang YP; Liu GY
Arthritis Res Ther; 2022 May; 24(1):121. PubMed ID: 35606782
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of primary Sjögren's syndrome related lymphocytic interstitial pneumonia.
Dong X; Gao YL; Lu Y; Zheng Y
Clin Rheumatol; 2021 Feb; 40(2):601-612. PubMed ID: 32613392
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary involvement in primary Sjögren's syndrome, as measured by the ESSDAI.
Heus A; Arends S; Van Nimwegen JF; Stel AJ; Nossent GD; Bootsma H
Scand J Rheumatol; 2020 Jan; 49(1):38-46. PubMed ID: 31556344
[No Abstract] [Full Text] [Related]
37. Predicting the risk of interstitial lung disease in patients with primary Sjögren's syndrome: Novel nomogram and elevated Th2 cells.
Wang Y; Jia Y; Qin Y; Feng M; Liang Z; Zhao X; Gao C; Guo H; Luo J
Mol Immunol; 2024 Apr; 168():25-37. PubMed ID: 38382243
[TBL] [Abstract][Full Text] [Related]
38. Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
Berardicurti O; Marino A; Genovali I; Navarini L; D'Andrea S; Currado D; Rigon A; Arcarese L; Vadacca M; Giacomelli R
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048669
[TBL] [Abstract][Full Text] [Related]
39. Clinical profiles of SS-ILD compared with SS-NILD in a Chinese population: a retrospective analysis of 735 patients.
Guo T; Long Y; Shen Q; Guo W; Duan W; Ouyang X; Peng H
Ann Med; 2021 Dec; 53(1):1340-1348. PubMed ID: 34402690
[TBL] [Abstract][Full Text] [Related]
40. Factors associated with secondary immune thrombocytopenia in patients with primary Sjögren's syndrome: a retrospective study of 639 cases.
Luo J; Song WJ; Chen JQ; Yang GY; Yang JY; Yu XB; Huang ZW; Xu Y; Wang JM; Tao QW
Clin Exp Rheumatol; 2022 Dec; 40(12):2245-2252. PubMed ID: 35383565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]